NASDAQ: CRDL - Cardiol Therapeutics Inc.

Lønnsomhet i seks måneder: -51.52%
Utbytte: 0.00%
Sektor: Healthcare

Kampanjeplan Cardiol Therapeutics Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet Cardiol Therapeutics Inc.

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx for patients hospitalized with COVID-19, as well as for the treatment of recurrent pericarditis and acute myocarditis.

flere detaljer
The company is also developing subcutaneous formulation of CardiolRx for the treatment of fibrosis and inflammation in the heart that is related with the development and progression of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2019-01-15
ISIN CA14161Y2006
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета cad
Сайт https://www.cardiolrx.com
Цена ао 0.9958
Prisendring per dag: -3.38% (0.9936)
Prisendring per uke: -14.29% (1.12)
Prisendring per måned: -18.64% (1.18)
Prisendring over 3 måneder: -26.72% (1.31)
Prisendring over seks måneder: -51.52% (1.98)
Prisendring per år: -50% (1.92)
Prisendring over 3 år: -29.93% (1.37)
Prisendring over 5 år: -60.82% (2.45)
Prisendring siden begynnelsen av året: -25% (1.28)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV 2.51 6
P/E 0 0
EV/EBITDA -1.23 0
Total: 3.25

Effektivitet

Navn Betydning Karakter
ROA, % -76.64 0
ROE, % -99.58 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.0059 10
Total: 9.6

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 120.28 10
Lønnsomhet EPS, % 6.4 1
Total: 4.2
Flere detaljer

Institusjoner Volum Dele, %
MMCAP International, Inc. SPC 2953300 4.33
AdvisorShares Investments, LLC 1189978 1.75
Tejara Capital Ltd 1116676 1.64
AXS Investments, LLC 697651 1.02
Lion Street Advisors, LLC 192700 0.28
Bank of Montreal/Can/ 104479 0.15
We Are One Seven, LLC 100000 0.15
Laird Norton Trust Company, LLC 100000 0.15
Cambridge Investment Research Advisors Inc. 85201 0.12
Credit Suisse Ag/ 80000 0.12

ETFDele, %Lønnsomhet for året, %Utbytte, %
AdvisorShares Pure Cannabis ETF 6.51027 -3.73 1.68573
6.51-3.731.69



Veileder Stillingstittel Betaling Fødselsår
Mr. David G. Elsley MBA President, CEO & Director 550.14k
Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA CFO, Corporate Secretary & Director 216.79k
Mr. Bernard Lim B.Sc. Chief Operating Officer 379.39k
Dr. Andrew Warwick Hamer M.D. Chief Medical Officer & Head of Research & Development 549.01k 1962 (63 år)
Trevor Burns Investor Relations N/A
Mr. John A. Geddes BSCPT, MBA Vice President of Corporate Development

Adresse: Canada, Oakville, 2265 Upper Middle Road East - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.cardiolrx.com